A. Renaud

1.7k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

A. Renaud is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, A. Renaud has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in A. Renaud's work include Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Renaud is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Renaud collaborates with scholars based in France, Netherlands and Canada. A. Renaud's co-authors include Nico van Zandwijk, Jan Festen, C. Schaake-Koning, B. Maat, Patrick Rodrigus, Harry Bartelink, Jean‐Paul Sculier, Otilia Dalesio, Mia G.J. Koolen and Anne Kirkpatrick and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

A. Renaud

13 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1992 998 citations C. Schaake-Koning, Walter Van den Bogaert et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Renaud France	10	883	534	214	201	150	14	1.3k
NM Bleehen United Kingdom	13	461 0.5×	408 0.8×	86 0.4×	260 1.3×	153 1.0×	22	1.1k
Edgar Ben‐Josef United States	19	973 1.1×	408 0.8×	256 1.2×	324 1.6×	339 2.3×	34	1.6k
Koichi Kurishima Japan	19	889 1.0×	550 1.0×	73 0.3×	313 1.6×	115 0.8×	92	1.4k
Stephen G. Chun United States	19	981 1.1×	687 1.3×	375 1.8×	232 1.2×	363 2.4×	67	1.6k
Gregory N. Gan United States	20	954 1.1×	807 1.5×	239 1.1×	572 2.8×	168 1.1×	60	1.8k
Libor Havel Czechia	21	980 1.1×	1.2k 2.3×	83 0.4×	249 1.2×	81 0.5×	54	1.6k
Kaoru Matsui Japan	20	1.4k 1.6×	1000 1.9×	55 0.3×	394 2.0×	94 0.6×	62	1.9k
Yoshiki Takada Japan	17	1.7k 1.9×	878 1.6×	519 2.4×	141 0.7×	443 3.0×	36	2.0k
Gerarda J.M. Herder Netherlands	19	911 1.0×	380 0.7×	65 0.3×	154 0.8×	402 2.7×	45	1.2k
Katrien Vandecasteele Belgium	19	477 0.5×	290 0.5×	289 1.4×	129 0.6×	255 1.7×	57	1.1k

Countries citing papers authored by A. Renaud

Since Specialization

Citations

This map shows the geographic impact of A. Renaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Renaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Renaud more than expected).

Fields of papers citing papers by A. Renaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Renaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Renaud. The network helps show where A. Renaud may publish in the future.

Co-authorship network of co-authors of A. Renaud

This figure shows the co-authorship network connecting the top 25 collaborators of A. Renaud. A scholar is included among the top collaborators of A. Renaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Renaud. A. Renaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Diop, Khoudia, Myriam Benlaïfaoui, Julie Malo, et al.. (2025). Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors. Gut Pathogens. 17(1). 21–21. 2 indexed citations

Houtte, P. Van, Jean Klášterský, A. Renaud, et al.. (2015). Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 131–137.

Lauber, Sabine, et al.. (2005). Biophysical and Biological Studies of End-Group-Modified Derivatives of Pep-1. Biochemistry. 44(48). 15799–15811. 44 indexed citations

Gingras, Denis, et al.. (2001). Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound.. PubMed. 21(1A). 145–55. 54 indexed citations

Gingras, Denis, et al.. (2000). Shark Cartilage Extracts as Antiangiogenic Agents: Smart Drinks or Bitter Pills?. Cancer and Metastasis Reviews. 19(1-2). 83–86. 22 indexed citations

Coudray‐Lucas, C., Elisabeth Lasnier, A. Renaud, et al.. (1999). Is α-ketoisocaproyl-glutamine a suitable glutamine precursor to sustain fibroblast growth?. Clinical Nutrition. 18(1). 29–33. 56 indexed citations

Schaake-Koning, C., W. Van den Bogaert, Otilia Dalesio, et al.. (1994). Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups. Lung Cancer. 10. S263–S270. 22 indexed citations

Schaake-Koning, C., W. Van den Bogaert, Otilia Dalesio, et al.. (1993). Radiotherapy combined with low-dose cisplatin; results of the EORTC 08844 phase III study by the EORTC Radiotherapy and Lung Cancer Cooperative Groups. Lung Cancer. 9(1-6). 245–248. 2 indexed citations

Staquet, M. & A. Renaud. (1993). Double-blind, randomized trial of piroxicam and codeine in cancer pain. Current Therapeutic Research. 53(4). 435–440. 9 indexed citations

10.

Schaake-Koning, C., Walter Van den Bogaert, Otilia Dalesio, et al.. (1992). Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer. New England Journal of Medicine. 326(8). 524–530. 998 indexed citations breakdown →

11.

Renaud, A., Patrick Lestienne, David L. Hughes, Joseph G. Bieth, & J. L. Dimicoli. (1983). Mapping of the S' subsites of porcine pancreatic and human leucocyte elastases.. Journal of Biological Chemistry. 258(13). 8312–8316. 32 indexed citations

12.

Dimicoli, Jean‐Luc, A. Renaud, & Joseph G. Bieth. (1980). The Indirect Mechanism of Action of the Trifluoroacetyl Peptides on Elastase. European Journal of Biochemistry. 107(2). 423–432. 15 indexed citations

13.

Dimicoli, J. L., A. Renaud, Patrick Lestienne, & Joseph G. Bieth. (1979). The interaction of trifluoroacetyl peptide chloromethyl ketones with porcine pancreatic elastase. Direct evidence for nonproductive enzyme.inhibitor complexes.. Journal of Biological Chemistry. 254(12). 5208–5218. 19 indexed citations

14.

Lestienne, Patrick, J. L. Dimicoli, A. Renaud, & Joseph G. Bieth. (1979). Inhibition of human leukocyte elastase by acetyl and trifluoroacetyl oligopeptide chloromethyl ketones.. Journal of Biological Chemistry. 254(12). 5219–5221. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact